HemaSphere (Jun 2022)

PB2132: COPANLISIB PLUS RITUXIMAB-BENDAMUSTINE FOR RELAPSED-REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: RECRUITMENT UPDATE ON AN ONGOING PHASE II TRIAL OF THE FONDAZIONE ITALIANA LINFOMI (FIL_COPA-RB)

  • M. Novo,
  • A. Castellino,
  • A. Chiappella,
  • G. Ciccone,
  • M. Balzarotti,
  • A. Arcari,
  • E. Scarpa,
  • A. Tucci,
  • N. Di Renzo,
  • G. Tarantini,
  • G. Gini,
  • M. Moretti,
  • D. Mannina,
  • A. Di Rocco,
  • M. Spina,
  • U. Vitolo

DOI
https://doi.org/10.1097/01.HS9.0000851360.15794.a8
Journal volume & issue
Vol. 6
pp. 2003 – 2004

Abstract

Read online

No abstracts available.